Our Technology: Restore with Neuroprosthetics
Restore Fundamental Human Needs.
Our neuroprosthetics are designed to help people get their lives back by restoring lost functions.
Our Technology: Restore with Neuroprosthetics
Our neuroprosthetics are designed to help people get their lives back by restoring lost functions.
The Product
See patients with paralysis who received the brain.io™ implant in Australia use the neuroprosthetic to perform activities of daily living without movement.
Fully implanted components with no visible effects on the body.
Patterns of thinking are translated directly into digital commands to control any device.
Designed to be a simple-to-use and dependable technology that works immediately.
Designed to be fully customizable to patient needs and adapt over time.
brain.io™ gives patients access to fundamental human needs. Each device replaces a key function of an intact motor neuron in order to record, transmit, translate, and act on brain signals.
The node consists of the stentrode™ and our internal receiver-transmitter unit that is placed in the chest under the skin. It records brain signals from the motor cortex and provides wireless transmission of raw data to the external devices.
The axon consists of our external receiver-transmitter unit and our signal control unit. The axon wirelessly detects raw brain signals from the node and translates them into standardized digital commands that can be recognized by any Bluetooth device.
Our end user software, brain.io™, is a hands-free, thought-controlled platform that uses translated brain signals to restore motor capabilities to achieve digital freedom.
DISCLAIMER: Devices are limited by United States Federal law to investigational use.
Synchron is the only company to have FDA approval to conduct clinical trials of a permanently implanted BCI. We are rapidly progressing towards a world first pivotal trial for an implantable BCI.
SWITCH 1 First In Human
Melbourne, AUS
SWITCH 2 Early Feasibility Study
Melbourne, Sydney and Brisbane, AUS
COMMAND Early Feasibility Study
New York City and Pittsburgh, USA